Temozolomide resistance in the high HOXA9/HOXA10-expressing GBM cell line was independent of MGMT status, and the PI3K pathway was considered to be an upstream regulator of HOX genes that can be targeted to overcome the resistance [9]. The gene discussed is HOXA10; the disease is glioblastoma.